Industry Reports
Johnson & Johnson Reports 2016 First-Quarter Results
Johnson & Johnson announced sales of $17.5 billion for the first quarter of 2016, an increase of 0.6% as compared to the first quarter...
Drug Research
Baxter announced the launch of a ready-to-use VANCOMYCIN Injection in sodium chloride for US
Only Manufacturer to Offer the Antibiotic in a Ready-to-Use Premixed Presentation World pharma today/Press releases /-Advancing Baxter’s longstanding commitment to provide...
News
Sanofi Invests €300 Million in its Biologics Site in Belgium
Sanofi announced a €300 million investment to expand its site in Geel, Belgium. The investment furthers Sanofi’s commitment to driving the future of biologics...
News
Genentech to Present New Data at AAN Showing Superior Efficacy of Investigational Medicine
Genentech, a member of the Roche group announced that new data from three Phase III studies of the investigational medicine OCREVUS™ (ocrelizumab) will...
Drug Research
Boehringer Ingelheim and Eli Lilly company plans to conduct Jardiance® (empagliflozin) to be studied for the treatment of people with chronic heart failure
New studies will evaluate the effect of JARDIANCE for the treatment of chronic heart failure There are approximately 26 million people worldwide,...
Industry Reports
Boehringer Ingelheim has a successful 2015 financial year with net sales increased by 4.1%
Net sales rise to 14.8 billion euros (currency-adjusted: +4.1 per cent; +11.1 per cent in euro terms) Operating income improves markedly to 2.3...
Industry Reports
Teva to Report First Quarter 2016 Financial Results on May 9, 2016
Teva Pharmaceutical Industries Ltd announced that it will release its first quarter 2016 financial results on Monday, May 9, 2016 at 7:00 a.m. ET....
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read